DSM Biomedical, a global leader in biomedical materials, today announced the development of VitroStealth™, a breakthrough non-biofouling (NBF) coating technology.
DSM PTG, part of DSM Biomedical, a global leader in biomedical materials science, today announced the availability of Bionate® II PCU, a versatile medical polymer with built-in surface technology designed for chronic implants.
DSM Biomedical, a global leader in biomedical materials science, today announced a major step forward in the development of a new polyethylene polymer platform intended to improve the mechanical properties and long-term stability of hip and knee implants.
DSM PTG, part of DSM Biomedical, a global leader in biomedical materials,
today announced the company’s participation in the upcoming 2009 International
Medical Devices Conference & Expo (IMD EXPO).
DSM Biomedical, a global leader in biomedical materials, today announced the
addition of three experts to its Scientific Advisory Board. Established in
July 2007, the Board supports DSM Biomedical’s research and development
strategy by advising on its scientific and technological quality, validity of
hypotheses, and clinical relevance.
DSM and the Maastricht University Medical Center+ (the Maastricht academic
hospital and the Faculty of Health, Medicine and Life Sciences of Maastricht
University) today announce the successful completion of the three projects
initiated as part of the Bioterials collaboration started in 2005.
DSM Biomedical, a global company serving the medtech and biotech industries
and part of Royal DSM N.V., announces two customers, AxioMed Spine and
Sunshine Heart, are celebrating commercial and clinical success of their
medical devices made with proprietary DSM Biomedical polymers.
DSM Biomedical, a global company serving the medtech and biotech industries
and part of Royal DSM N.V., announced today that it has extended its
lubricious ComfortCoat™ technology platform with the design of a
hemocompatible antimicrobial coating to thwart intravascular catheter-related
bloodstream infections.
Royal DSM N.V., the global Life Sciences and Materials Sciences company
headquartered in the Netherlands, today announces that DSM Biomedical obtained
an exclusive world-wide license for a unique drug & biologics delivery system
developed by MediVas LLC. Integrated into DSM’s Trancerta® Drug Delivery
platform, this will open up a broad range of opportunities for next generation
drug delivery. DSM’s activities in this field are an illustration of the way
DSM is leveraging its competences in Materials Sciences into Life Sciences
applications.
Advanced lubricious hydrophilic coating now available, designed to enhance
maneuverability of metal guidewires, uncoiled and coiled, in minimally
invasive procedures.
DSM PTG (formerly The Polymer Technology Group/"PTG"), a preeminent
biomaterials company, announced today that the Company has recently surpassed
the 100 employee mark, necessitated by the robust demand for its proprietary
biomaterials and medical device components. The Company also announced that it
has appointed two new executives to its management team: Frederik G.
Hoogendijk is DSM PTG's Chief Financial Officer (CFO), effective immediately;
and, Robert F. Evans assumes the role of Vice President of Global Sales &
Marketing, also effective immediately.
